Edmond de Rothschild Holding’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-130
| Closed | -$20.4K | – | 583 |
|
2024
Q4 | $20.4K | Hold |
130
| – | – | ﹤0.01% | 547 |
|
2024
Q3 | $23.1K | Hold |
130
| – | – | ﹤0.01% | 573 |
|
2024
Q2 | $21.9K | Hold |
130
| – | – | ﹤0.01% | 606 |
|
2024
Q1 | $21.6K | Hold |
130
| – | – | ﹤0.01% | 602 |
|
2023
Q4 | $21.5K | Hold |
130
| – | – | ﹤0.01% | 614 |
|
2023
Q3 | $20.2K | Hold |
130
| – | – | ﹤0.01% | 624 |
|
2023
Q2 | $20.3K | Hold |
130
| – | – | ﹤0.01% | 643 |
|
2023
Q1 | $21.1K | Hold |
130
| – | – | ﹤0.01% | 653 |
|
2022
Q4 | $20.8K | Hold |
130
| – | – | ﹤0.01% | 713 |
|
2022
Q3 | $18K | Hold |
130
| – | – | ﹤0.01% | 742 |
|
2022
Q2 | $19K | Hold |
130
| – | – | ﹤0.01% | 730 |
|
2022
Q1 | $21K | Hold |
130
| – | – | ﹤0.01% | 739 |
|
2021
Q4 | $25K | Sell |
130
-1,400
| -92% | -$269K | ﹤0.01% | 763 |
|
2021
Q3 | $309K | Hold |
1,530
| – | – | 0.01% | 490 |
|
2021
Q2 | $308K | Hold |
1,530
| – | – | 0.01% | 478 |
|
2021
Q1 | $269K | Sell |
1,530
-130
| -8% | -$22.9K | 0.01% | 441 |
|
2020
Q4 | $281K | Hold |
1,660
| – | – | 0.01% | 402 |
|
2020
Q3 | $269K | Buy |
1,660
+130
| +8% | +$21.1K | 0.01% | 365 |
|
2020
Q2 | $249K | Buy |
1,530
+1,400
| +1,077% | +$228K | 0.01% | 350 |
|
2020
Q1 | $17K | Sell |
130
-520
| -80% | -$68K | ﹤0.01% | 515 |
|
2019
Q4 | $90K | Hold |
650
| – | – | ﹤0.01% | 432 |
|
2019
Q3 | $76K | Hold |
650
| – | – | ﹤0.01% | 435 |
|
2019
Q2 | $84K | Hold |
650
| – | – | ﹤0.01% | 425 |
|
2019
Q1 | $84K | Sell |
650
-600
| -48% | -$77.5K | ﹤0.01% | 440 |
|
2018
Q4 | $139K | Hold |
1,250
| – | – | ﹤0.01% | 433 |
|
2018
Q3 | $171K | Buy |
1,250
+600
| +92% | +$82.1K | ﹤0.01% | 453 |
|
2018
Q2 | $78K | Sell |
650
-480
| -42% | -$57.6K | ﹤0.01% | 555 |
|
2018
Q1 | $136K | Hold |
1,130
| – | – | ﹤0.01% | 514 |
|
2017
Q4 | $142K | Sell |
1,130
-460
| -29% | -$57.8K | ﹤0.01% | 531 |
|
2017
Q3 | $211K | Sell |
1,590
-360
| -18% | -$47.8K | 0.01% | 468 |
|
2017
Q2 | $245K | Buy |
1,950
+220
| +13% | +$27.6K | 0.01% | 449 |
|
2017
Q1 | $205K | Sell |
1,730
-60
| -3% | -$7.11K | 0.01% | 470 |
|
2016
Q4 | $193K | Sell |
1,790
-1,425
| -44% | -$154K | 0.01% | 484 |
|
2016
Q3 | $373K | Buy |
3,215
+315
| +11% | +$36.5K | 0.01% | 428 |
|
2016
Q2 | $297K | Sell |
2,900
-1,525
| -34% | -$156K | 0.01% | 443 |
|
2016
Q1 | $459K | Sell |
4,425
-10,775
| -71% | -$1.12M | 0.01% | 371 |
|
2015
Q4 | $1.93M | Sell |
15,200
-4,405
| -22% | -$559K | 0.05% | 203 |
|
2015
Q3 | $2.24M | Buy |
19,605
+6,079
| +45% | +$695K | 0.06% | 195 |
|
2015
Q2 | $1.82M | Buy |
+13,526
| New | +$1.82M | 0.04% | 228 |
|